Study of Decitabine and Tetrahydrouridine (THU) in Patients With Sickle Cell Disease
Clinical trial NCT01685515 · COMPLETED
Trial details
- NCT number
- NCT01685515
- Sponsor
- Yogen Saunthararajah
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2018-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.